| Business Name: |
Asha J Chemmalakuzhy MD |
| Contact Person: |
Asha Chemmalakuzhy |
| Address: |
2020 State Hwy 114
Ste. 190, Grapevine, Texas 76051 |
| Phone Number: |
(214) 358-2300 |
| Website Address: |
dneph.com |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| Share This Business: |
|
| Related Businesses: |
Paul Vincent MD - Grapevine, TX 76051
Clncl Pedtrc Assc - Grapevine, TX 76051
Jamal Saira MD - Grapevine, TX 76051
Purgett Thomas J MD - Grapevine, TX 76051
Vera Richard L MD - Grapevine, TX 76051
Davidson Scott D MD - Grapevine, TX 76051
Arora Neeraj MD - Grapevine, TX 76051
Capili Carleo MD - Grapevine, TX 76051
Cowen Alan MD - Grapevine, TX 76051
Pittard Carlton D MD - Grapevine, TX 76051
Surgical Group of North Texas - Grapevine, TX 76051
Nannette F Crow M D Ppllc - Grapevine, TX 76051
Camp Braveskin - Grapevine, TX 76051
Graham M Alexander D P A - Grapevine, TX 76051
Aurora Vikas MD - Grapevine, TX 76051
Wise David A MD - Grapevine, TX 76051
Vallejo-Craig Pamela MD - Grapevine, TX 76051
Ammons David H MD - Grapevine, TX 76051
Donegan Kerry M MD - Grapevine, TX 76051
Cook Children's Hospital - Grapevine, TX 76051
|
The company Asha J Chemmalakuzhy MD provides B2C services in the form of Doctors from its single location in Texas.
1 to 4 employees work for Asha J Chemmalakuzhy MD, and the business now earns $500.000 to $999.999 per annum.
Asha J Chemmalakuzhy MD was launched in 0 and is classified under SIC code and category , and NAICS number and grouping .
To contact Asha J Chemmalakuzhy MD, please call Asha Chemmalakuzhy with the phone number (214) 358-2300 or visit its single location at 2020 State Hwy 114
Ste. 190 in Grapevine, Texas 76051.
The location of the single location can also be found using the coordinates 32.93377,-97.09572.
Read more details about this business on the webpage dneph.com or follow the company’s social media accounts, on Twitter and on Facebook.